scout
|Videos|February 9, 2021

TAILORx Trial

A review of the TAILORx trial using the Oncotype DX assay to inform decisions in the adjuvant setting for treatment of HR+, HER2- breast cancer.


Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.


Latest CME